Unfractionated heparin-clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy.

Citation data:

Atherosclerosis, ISSN: 1879-1484, Vol: 241, Issue: 1, Page: 151-6

Publication Year:
2015
Usage 92
Abstract Views 85
Link-outs 7
Captures 27
Readers 20
Exports-Saves 7
Citations 25
Citation Indexes 25
PMID:
25988359
DOI:
10.1016/j.atherosclerosis.2015.04.794
ClinicalTrials.gov Identifier:
NCT01218776
Author(s):
Bugiardini, Raffaele; Dorobantu, Maria; Vasiljevic, Zorana; Kedev, Sasko; Knežević, Božidarka; Miličić, Davor; Calmac, Lucian; Trninic, Dijana; Daullxhiu, Irfan; Cenko, Edina; Ricci, Beatrice; Puddu, Paolo Emilio; Manfrini, Olivia; Koller, Akos; Badimon, Lina; ISACS-TC Investigators Show More Hide
Publisher(s):
Elsevier BV
Tags:
Medicine
article description
We sought explore the relative benefits of unfractionated heparin (UFH) compared with enoxaparin, alone or in combination with clopidogrel, in ST-segment elevation myocardial infarction (STEMI) patients not undergoing reperfusion therapy.